Zomedica Corp (ZOM)

$0.151

Market is closed - opens 7 PM, 17 Jun 2024

Insights on Zomedica Corp

  • Increasing Revenue

    Revenue is up for the last 5 quarters, 5.48M → 7.33M (in $), with an average increase of 6.9% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -491.0K → -22.40M (in $), with an average decrease of 2231.7% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 41.3% return, outperforming this stock by 69.4%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 77.1% return, outperforming this stock by 160.4%

Performance

  • $0.15
    $0.16
    $0.15
    downward going graph

    0.0%

    Downside

    Day's Volatility :3.78%

    Upside

    3.78%

    downward going graph
  • $0.12
    $0.25
    $0.15
    downward going graph

    20.0%

    Downside

    52 Weeks Volatility :51.02%

    Upside

    38.78%

    downward going graph

Returns

PeriodZomedica CorpSector (Health Care)Index (Russel 2000)
3 Months
15.71%
0.4%
0.0%
6 Months
-21.76%
8.7%
0.0%
1 Year
-25.25%
10.3%
0.0%
3 Years
-83.29%
16.5%
-22.7%

Highlights

Market Capitalization
152.5M
Book Value
$0.24
Earnings Per Share (EPS)
-0.04
Wall Street Target Price
0.44
Profit Margin
-143.66%
Operating Margin TTM
-165.86%
Return On Assets TTM
-8.23%
Return On Equity TTM
-15.07%
Revenue TTM
26.0M
Revenue Per Share TTM
0.03
Quarterly Revenue Growth YOY
14.2%
Gross Profit TTM
13.7M
EBITDA
-27.6M
Diluted Eps TTM
-0.04
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.01
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    37%Hold
    62%Sell
Based on 8 Wall street analysts offering stock ratings for Zomedica Corp(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
3
3
3
Sell
5
5
5

Analyst Forecast

What analysts predicted

Upside of 191.39%

Current $0.15
Target $0.44

Technicals Summary

Sell

Neutral

Buy

Zomedica Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zomedica Corp
Zomedica Corp
-13.07%
-21.76%
-25.25%
-83.29%
-36.42%
Stryker Corporation
Stryker Corporation
3.08%
18.36%
15.84%
32.91%
75.66%
Boston Scientific Corp.
Boston Scientific Corp.
2.83%
38.28%
42.04%
77.07%
88.69%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-2.08%
16.57%
-5.03%
-13.57%
41.74%
Abbott Laboratories
Abbott Laboratories
-0.39%
-4.05%
-2.83%
-7.12%
26.36%
Medtronic Plc
Medtronic Plc
-5.68%
-2.43%
-8.88%
-35.28%
-16.73%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zomedica Corp
Zomedica Corp
NA
NA
NA
-0.01
-0.15
-0.08
NA
0.24
Stryker Corporation
Stryker Corporation
39.2
39.2
2.92
11.96
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
64.67
64.67
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.63
37.63
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
32.23
32.23
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
29.59
29.59
1.52
5.2
0.07
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zomedica Corp
Zomedica Corp
Sell
$152.5M
-36.42%
NA
-143.66%
Stryker Corporation
Stryker Corporation
Buy
$130.7B
75.66%
39.2
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$113.1B
88.69%
64.67
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.8B
41.74%
37.63
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$180.0B
26.36%
32.23
13.96%
Medtronic Plc
Medtronic Plc
Buy
$108.6B
-16.73%
29.59
11.36%

Company Information

zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.

Organization
Zomedica Corp
Employees
144
CEO
Mr. Larry C. Heaton II
Industry
Health Technology

FAQs